Soligenix to present key findings on HyBryte™ and SGX302 at USCLC workshop and AAD annual meeting
Soligenix, Inc announced its lead investigators for the cutaneous T-cell lymphoma (CTCL) and psoriasis programs are presenting findings from recent supportive trials with HyBryte™ (synthetic hypericin) in the… read more.
